[PDF][PDF] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell metabolism, 2021 - cell.com
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell Metabolism, 2021 - cell.com
(Cell Metabolism 33, 2174–2188. e1–e5, November 2, 2021) It was brought to the authors'
attention by readers that ARDS was not adequately defined. The STAR Methods have now …

[HTML][HTML] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell Metabolism, 2021 - Elsevier
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

[引用][C] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell Metabolism, 2021 - cir.nii.ac.jp
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue
infectivity by SARS-CoV-2 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy… - Cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

[HTML][HTML] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell …, 2021 - ncbi.nlm.nih.gov
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell …, 2021 - europepmc.org
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

[PDF][PDF] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gomez-Banoy, JD Lau… - Cell …, 2021 - researchgate.net
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell …, 2021 - europepmc.org
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

[HTML][HTML] Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell …, 2021 - ncbi.nlm.nih.gov
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …